In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: DXC is deeply undervalued with a current price of $14.89 versus a PERT fair value of $112.20 and Monte Carlo median at $174.15, indicating significant upside potential. However, the company’s poor financial health and high valuation volatility (105% coefficient of variation) signal elevated investment risk. Mixed valuation methods heighten uncertainty, especially given conflicting low P/E targets versus strong DCF and EV/EBITDA results.